ID: ALA3394691

Max Phase: Preclinical

Molecular Formula: C21H19FN6O3S

Molecular Weight: 454.49

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1nc(-n2cnn(CCOc3ccc(F)cc3)c2=O)sc1C(=O)NCc1cccnc1

Standard InChI:  InChI=1S/C21H19FN6O3S/c1-14-18(19(29)24-12-15-3-2-8-23-11-15)32-20(26-14)27-13-25-28(21(27)30)9-10-31-17-6-4-16(22)5-7-17/h2-8,11,13H,9-10,12H2,1H3,(H,24,29)

Standard InChI Key:  UKGARQJWXPNPOQ-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 454.49

Molecular Weight (Monoisotopic): 454.1223

AlogP: 2.34

#Rotatable Bonds: 8

Polar Surface Area: 103.93

Molecular Species: NEUTRAL

HBA: 9

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 9

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 12.97

CX Basic pKa: 4.82

CX LogP: 2.47

CX LogD: 2.47

Aromatic Rings: 4

Heavy Atoms: 32

QED Weighted: 0.44

Np Likeness Score: -2.26

References

1. Sun S, Zhang Z, Pokrovskaia N, Chowdhury S, Jia Q, Chang E, Khakh K, Kwan R, McLaren DG, Radomski CC, Ratkay LG, Fu J, Dales NA, Winther MD..  (2015)  Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors.,  23  (3): [PMID:25555732] [10.1016/j.bmc.2014.12.014]

Source

Source(1):

• Scientific Literature